William Fc Rigby MD
Rheumatoid Arthritis & Related
Professor, Medicine, Geisel School of Medicine
Join to View Full Profile
1 Medical Center DriveLebanon, NH 03756
Phone+1 603-650-8622
Fax+1 603-640-1928
Dr. Rigby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Rheumatology, 1985 - 1986- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1981 - 1984
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1979 - 1980
Harvard Medical SchoolClass of 1979
Certifications & Licensure
NH State Medical License 1983 - 2027
VT State Medical License 1982 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Rheumatoid Arthritis Memory B Cells and Abatacept Start of enrollment: 2019 Jun 02
Publications & Presentations
PubMed
- 2 citationsUpadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY rando...Josef S Smolen, Paul Emery, William Rigby, Yoshiya Tanaka, Juan Ignacio Vargas
RMD Open. 2025-05-11 - 3 citationsThe thematic role of extracellular loop of VraG in activation of the membrane sensor GraS in a cystic fibrosis MRSA strain differs in nuance from the CA-MRSA strain JE2.Junho Cho, William F C Rigby, Ambrose L Cheung
Plos One. 2022-01-01 - 6 citationsBenefit-Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis.Philip G. Conaghan, Stanley Cohen, Gerd R Burmester, Eduardo Mysler, Peter Nash
Rheumatology and Therapy. 2021-11-23
Press Mentions
Basic and Clinical Immunology Online Boot CampJuly 3rd, 2017
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
